Validation demo · simulated data
Weekly Growth Brief
A concise decision brief for studio leads: what changed, what worked and what deserves attention next.
Health score
77 / 100
+5 pts
D1 retention
15.4%
+0.6 pp
ARPDAU
R$ 2.31
+7.9%
Paid spend
Held
No scale-up
What changed
↑
Retention recovered
D1 improved after onboarding traffic stabilized.
↑
Monetization improved
ARPDAU rose 7.9% without payer conversion deterioration.
→
Acquisition held
Spend remained flat while product issues were investigated.
Next week's focus
Run the mobile Step 3 experiment
This remains the highest-confidence product opportunity. Hold ad scaling until the test has enough data for a decision.
Executive summary
Product health is improving, but mobile onboarding remains the primary constraint on efficient growth.